Nyrada Inc

NYR

Company Profile

  • Business description

    Nyrada Inc is a preclinical-stage, drug discovery, and development company, specializing in novel small-molecule drugs to treat cardiovascular and neurological diseases. The company's two programs center on cholesterol-lowering and brain injury, each targeting market sectors of notable size and unmet clinical needs. The programs are focused on developing an oral, small molecule cholesterol-lowering drug, and a drug to treat secondary brain damage following a stroke or traumatic brain injury.

  • Contact

    828 Pacific Highway
    Suite 2, Level 3
    GordonNSW2072
    AUS

    T: +61 294983390

    https://www.nyrada.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2025

    Employees

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,637.8012.900.15%
CAC 407,779.728.38-0.11%
DAX 4023,933.23104.96-0.44%
Dow JONES (US)42,093.365.34-0.01%
FTSE 1008,716.459.56-0.11%
HKSE23,573.38315.071.35%
NASDAQ19,146.4145.470.24%
Nikkei 22538,432.98710.581.88%
NZX 50 Index12,281.3180.95-0.65%
S&P 5005,899.2210.670.18%
S&P/ASX 2008,409.8012.900.15%
SSE Composite Index3,363.4523.510.70%

Market Movers